Argentinian pharmaceutical exports on the increase
This article was originally published in Scrip
Argentina's pharmaceutical exports are growing well and have more than doubled since 2003, a year after the country's economic crash. In the first nine months of this year they were worth $451.7 million, up by 22% compared with the same period last year, says INDEC, the national statistics institute.
You may also be interested in...
Patient access schemes have helped the Scottish Medicines Consortium recommend rare disease products, including Regeneron/Sanofi’s Libtayo for skin cancer.
In an exclusive interview, senior NICE director Meindert Boysen reveals the best advice he ever received and how companies whose products are under review can improve their chances of success.
Criticism of Novartis/Avexis’s controversial lottery style managed access program for Zolgensma has come largely from Europe, while other countries in Latin America and Asia have been far more receptive.